Photo from Pediatric Brain Tumor Foundation/LinkedIn
Aug 20, 2023, 16:30
Drug ONC201 nearly doubles survival rates for children with this deadly brain cancer – Pediatric Brain Tumor Foundation
Pediatric Brain Tumor Foundation shared on its LinkedIn page:
“Incredible news in the study of DIPG/DMG: Pediatric Brain Tumor Foundation-funded research led by Michigan Medicine’s Koschmann Lab and Venneti Lab reveals that the drug ONC201 nearly doubles survival rates for children with this deadly brain cancer.
This National Nonprofit Day, we thank our donors and fundraisers whose generosity led to this breakthrough. But we also need your help to make sure progress continues.
Many other breakthroughs for kids with brain cancer are yet to be discovered because researchers lack the funding they need. Help us close the research funding gap. Donate today at curethekids.org/givenow.”
Source: Pediatric Brain Tumor Foundation/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 15, 2024, 07:05
Nov 15, 2024, 07:03
Nov 15, 2024, 06:33
Nov 15, 2024, 05:57
Nov 14, 2024, 17:57